CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapydevice
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Age 16–80 years old
  • ✓Active EoE per consensus guidelines or undergoing upper endoscopy for clinical suspicion of EoE
  • ✓No prior history of dietary elimination therapy
Key exclusion· 6
  • ✕Concomitant eosinophilic gastroenteritis
  • ✕Any corticosteroid exposure in the 4 weeks prior to baseline endoscopic exam
  • ✕Previous esophageal surgery
  • ✕Medical instability that precludes safely performing upper endoscopy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02722148
NCT02722148N/ACompleted
CompareCT.gov

Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)

University of North Carolina, Chapel Hill·interventional·Posted Mar 29, 2016·Updated Apr 2, 2019

In Brief

A clinical study evaluating Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy for Eosinophilic Esophagitis. Completed, enrolled 24 participants across 1 site.

Detailed Summary

This is a prospective single center clinical trial of allergen-specific immune signature-guided dietary elimination therapy to assess the clinical effectiveness of this technique.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEosinophilic Esophagitis
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 29, 2016
Enrollment StartApr 21, 2016
Primary CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 10.3 years ago

Interventions

Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapydevice

A novel assay developed by the investigator to diagnose food allergens. Results from the assay are used to guide food elimination therapy for the treatment of Eosinophilic Esophagitis (EoE).